Racial Comparison of the Pharmacokinetics and Safety of Fixed-Dose Combination of Dapagliflozin/Sitagliptin in Western and Korean Healthy Adults.
西方與韓國健康成人中 Dapagliflozin/Sitagliptin 固定劑量聯合用藥的藥物動力學及安全性之種族比較。
Clin Ther 2024-08-23
Comparing Effectiveness and Safety of SGLT2 Inhibitors vs DPP-4 Inhibitors in Patients With Type 2 Diabetes and Varying Baseline HbA1c Levels.
比較SGLT2抑制劑與DPP-4抑制劑在2型糖尿病患者中對不同基線HbA1c水平的有效性和安全性。
JAMA Intern Med 2023-03-11
Development of Clinically Optimized Sitagliptin and Dapagliflozin Complex Tablets: Pre-Formulation, Formulation, and Human Bioequivalence Studies.
Sitagliptin和Dapagliflozin複合片的臨床優化製劑開發:前製劑、製劑和人體生物等效性研究。
Pharmaceutics 2023-05-01
A Comparison of the Pharmacokinetics and Safety of Dapagliflozin Formate, an Ester Prodrug of Dapagliflozin, to Dapagliflozin Propanediol Monohydrate in Healthy Subjects.
健康受試者中 Dapagliflozin Formate(Dapagliflozin 的酯前藥)的藥代動力學和安全性與 Dapagliflozin Propanediol Monohydrate 之比較。
Drug Des Devel Ther 2023-05-01
Fed and fasted bioequivalence assessment of two formulations of extended-release fixed-dose combination dapagliflozin/metformin (10/1,000 mg) tablets in healthy subjects.
健康受試者中兩種延長釋放固定劑量組合達帕格列酮/二甲双胍(10/1,000 毫克)片劑的飽食和禁食生物等效性評估。
Transl Clin Pharmacol 2023-07-18
Pharmacokinetic Variables of Dapagliflozin/Metformin Extended-release Fixed-dose Combination in Healthy Chinese Volunteers and Regional Comparison.
健康中國志願者及地區比較中達帕格列酮/二甲双胍延長釋放固定劑量組合的藥物動力學變數。
Clin Ther 2023-09-24
Pharmacokinetic Comparison Between a Fixed-Dose Combination of Empagliflozin L-Proline/Metformin and Empagliflozin/Metformin in Healthy Korean Subjects.
Empagliflozin L-Proline/Metformin 固定劑量組合與 Empagliflozin/Metformin 在韓國健康受試者中的藥代動力學比較。
Clin Pharmacol Drug Dev 2024-04-16
Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean Subjects.
兩種 Empagliflozin 配方在韓國健康受試者中的藥物動力學、安全性和耐受性比較。
Drug Des Devel Ther 2023-08-01
Comparative Safety Analysis of Empagliflozin in Type 2 Diabetes Mellitus Patients with Chronic Kidney Disease versus Normal Kidney Function: A Nationwide Cohort Study in Korea.
在韓國進行的糖尿病患者中,慢性腎臟病與正常腎功能之間 empagliflozin 的比較安全性分析:全國性群體研究。
Pharmaceutics 2023-10-30
The Real DAPSI: A Real-World Retrospective Study on Assessing the Efficacy and Safety of a Fixed-Dose Combination of Dapagliflozin and Sitagliptin in the Indian Population.
真實的DAPSI:關於評估達帕格列酮和席他格列汀固定劑量合併劑在印度人口中的療效和安全性的真實世界回顧性研究。
Cureus 2023-11-14
Retrospective Observational Study on Assessing Sitagliptin and Dapagliflozin as a Fixed-Dose Combination in the Indian Population With Type 2 Diabetes Mellitus: The SIDAXA Study.
印度人口中以固定劑量組合的Sitagliptin和Dapagliflozin評估為主題的二型糖尿病回顧性觀察研究:SIDAXA研究。
Cureus 2024-06-24